<DOC>
	<DOCNO>NCT00000337</DOCNO>
	<brief_summary>The purpose study determine effect selegiline subjective physiological effect cocaine challenge chronic crack abuser , evaluate clinical safety issue pertain selegeline , cocaine interaction chronic crack dependent population .</brief_summary>
	<brief_title>Infusion Laboratory : Protocol 1 - Selegeline - 2</brief_title>
	<detailed_description>To develop medication treatment cocaine addiction use medical human physio-neuro-psycho-immunology laboratory set . To characterize cocaine abuse population variety psychological physicologically measure time withdrawal pere post cocaine administration . To determine effect selegeline subjective physiological effect cocaine challenge chronic crack abuser . To evaluate clinical safety issue pertain selegeline , cocaine interaction chronic crack dependent population .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<criteria>M/F , age 2150 . Meet DSMIV criterion cocaine dependence . Agree condition study sign inform consent . Psychiatric disorder require medication therapy . History seizure . Pregnant and/or nuring woman . Dependence ETOH benzodiazepine sedative/hypnotics . Acute hepatitis . Other medical condtions deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>31 Years</minimum_age>
	<maximum_age>47 Years</maximum_age>
	<verification_date>August 1996</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>